<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Differentiation of <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">essential thrombocythemia</z:e> (ET) from <z:e sem="disease" ids="C0836924" disease_type="Disease or Syndrome" abbrv="">thrombocythemias</z:e> occurring in various subtypes of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPDs</z:e>) is controversial, because of the lack of uniform clinical and morphological criteria </plain></SENT>
<SENT sid="1" pm="."><plain>A retrospective clinicopathologic study was performed on 375 patients presenting with a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> and a platelet count exceeding 500 x 10(9/)l </plain></SENT>
<SENT sid="2" pm="."><plain>For comparison 35 patients with reactive <z:hpo ids='HP_0001894'>thrombocytosis</z:hpo> (RT) and five patients with a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-5q(-) syndrome) were enrolled into this study </plain></SENT>
<SENT sid="3" pm="."><plain>In addition to a complete clinicopathological work-up, procedures included histochemical and immunological staining techniques and morphometry of bone marrow biopsies for proper evaluation of megakaryocytes (CD61) and erythroid precursors (Ret40f) </plain></SENT>
<SENT sid="4" pm="."><plain>Because of the high patient's age on admission, relative survival rates with corresponding disease-specific loss of life expectancy were calculated </plain></SENT>
<SENT sid="5" pm="."><plain>Analysis of clinical and morphological characteristics, in particular megakaryopoiesis revealed features which enabled a clear-cut distinction between <z:e sem="disease" ids="C0836924" disease_type="Disease or Syndrome" abbrv="">thrombocythemias</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPDs</z:e> and thrombocythemic states in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>This rationale proved to be most important for the diagnostic discrimination of the 33 patients with initial (prefibrotic) stages of idiopathic <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (IMF) from ET (40 patients) </plain></SENT>
<SENT sid="7" pm="."><plain>A new set of relevant criteria for the diagnosis of IMF with special regard to early stages and its distinction from ET has been proposed </plain></SENT>
<SENT sid="8" pm="."><plain>Hemorrhagic episodes were more frequently observed in ET than in <z:e sem="disease" ids="C0836924" disease_type="Disease or Syndrome" abbrv="">thrombocythemias</z:e> associated with <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>) </plain></SENT>
<SENT sid="9" pm="."><plain>Computation of specific loss of life expectancy revealed two extremes: <z:e sem="disease" ids="C0836924" disease_type="Disease or Syndrome" abbrv="">thrombocythemia</z:e> in <z:mp ids='MP_0005481'>CML</z:mp> (81%) and ET (3%), whereas <z:e sem="disease" ids="C0836924" disease_type="Disease or Syndrome" abbrv="">thrombocythemias</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> and IMF did not show a significantly different life loss (19-22%) </plain></SENT>
<SENT sid="10" pm="."><plain>The revised criteria for ET, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> and IMF are reliable by taking histopathological features from bone marrow biopsies into consideration, particularly for the diagnosis of ET and its differentiation from <z:e sem="disease" ids="C0836924" disease_type="Disease or Syndrome" abbrv="">thrombocythemias</z:e> as a presenting symptom accompanying the various subtypes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPDs</z:e> </plain></SENT>
</text></document>